These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 21472182)

  • 41. Relevance of dopamine D(2)/neurotensin NTS1 and NMDA/neurotensin NTS1 receptor interaction in psychiatric and neurodegenerative disorders.
    Tanganelli S; Antonelli T; Tomasini MC; Beggiato S; Fuxe K; Ferraro L
    Curr Med Chem; 2012; 19(3):304-16. PubMed ID: 22335510
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of N-terminal modifications on neurotensin(8-13) analogues correlates peptide stability but not binding affinity with in vivo efficacy.
    Orwig KS; Lassetter MR; Hadden MK; Dix TA
    J Med Chem; 2009 Apr; 52(7):1803-13. PubMed ID: 19290594
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Neurotensin and neurotensin receptors: characteristic, structure-activity relationship and pain modulation--a review.
    Kleczkowska P; Lipkowski AW
    Eur J Pharmacol; 2013 Sep; 716(1-3):54-60. PubMed ID: 23500196
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Chimeric rat/human neurotensin receptors localize a region of the receptor sensitive to binding of a novel, species-specific, picomolar affinity peptide.
    Cusack B; Groshan K; McCormick DJ; Pang YP; Perry R; Phung CT; Souder T; Richelson E
    J Biol Chem; 1996 Jun; 271(25):15054-9. PubMed ID: 8662846
    [TBL] [Abstract][Full Text] [Related]  

  • 45. NTS2 modulates the intracellular distribution and trafficking of NTS1 via heterodimerization.
    Perron A; Sharif N; Sarret P; Stroh T; Beaudet A
    Biochem Biophys Res Commun; 2007 Feb; 353(3):582-90. PubMed ID: 17188644
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mimicking of Arginine by Functionalized N(ω)-Carbamoylated Arginine As a New Broadly Applicable Approach to Labeled Bioactive Peptides: High Affinity Angiotensin, Neuropeptide Y, Neuropeptide FF, and Neurotensin Receptor Ligands As Examples.
    Keller M; Kuhn KK; Einsiedel J; Hübner H; Biselli S; Mollereau C; Wifling D; Svobodová J; Bernhardt G; Cabrele C; Vanderheyden PM; Gmeiner P; Buschauer A
    J Med Chem; 2016 Mar; 59(5):1925-45. PubMed ID: 26824643
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Agonist and antagonist modulation of [35S]-GTP gamma S binding in transfected CHO cells expressing the neurotensin receptor.
    Hermans E; Geurts M; Maloteaux JM
    Br J Pharmacol; 1997 Aug; 121(8):1817-23. PubMed ID: 9283723
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Preparation and pharmacological evaluation of a novel series of 2-(phenylthio)benzo[b]thiophenes as selective MT2 receptor ligands.
    Mésangeau C; Fraise M; Delagrange P; Caignard DH; Boutin JA; Berthelot P; Yous S
    Eur J Med Chem; 2011 May; 46(5):1835-40. PubMed ID: 21392858
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pancreatic cancer bears overexpression of neurotensin and neurotensin receptor subtype-1 and SR 48692 counteracts neurotensin induced cell proliferation in human pancreatic ductal carcinoma cell line PANC-1.
    Wang JG; Li NN; Li HN; Cui L; Wang P
    Neuropeptides; 2011 Apr; 45(2):151-6. PubMed ID: 21272935
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Generation of RNA aptamers to the G-protein-coupled receptor for neurotensin, NTS-1.
    Daniels DA; Sohal AK; Rees S; Grisshammer R
    Anal Biochem; 2002 Jun; 305(2):214-26. PubMed ID: 12054450
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Stable expression of the mouse levocabastine-sensitive neurotensin receptor in HEK 293 cell line: binding properties, photoaffinity labeling, and internalization mechanism.
    Botto JM; Chabry J; Sarret P; Vincent JP; Mazella J
    Biochem Biophys Res Commun; 1998 Feb; 243(2):585-90. PubMed ID: 9480852
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Novel diastereomeric opioid tetrapeptides exhibit differing pharmacological activity profiles.
    Ioja E; Tourwé D; Kertész I; Tóth G; Borsodi A; Benyhe S
    Brain Res Bull; 2007 Sep; 74(1-3):119-29. PubMed ID: 17683797
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Increased ethanol consumption and preference in mice lacking neurotensin receptor type 2.
    Lee MR; Hinton DJ; Unal SS; Richelson E; Choi DS
    Alcohol Clin Exp Res; 2011 Jan; 35(1):99-107. PubMed ID: 21039631
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Differential involvement of intracellular domains of the rat NTS1 neurotensin receptor in coupling to G proteins: a molecular basis for agonist-directed trafficking of receptor stimulus.
    Skrzydelski D; Lhiaubet AM; Lebeau A; Forgez P; Yamada M; Hermans E; Rostene W; Pelaprat D
    Mol Pharmacol; 2003 Aug; 64(2):421-9. PubMed ID: 12869647
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The amide linker in nonpeptide neurotensin receptor ligands plays a key role in calcium signaling at the neurotensin receptor type 2.
    Thomas JB; Giddings AM; Olepu S; Wiethe RW; Warner KR; Sarret P; Longpre JM; Runyon SP; Gilmour BP
    Bioorg Med Chem Lett; 2015; 25(10):2060-4. PubMed ID: 25881832
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immunohistochemical distribution of NTS2 neurotensin receptors in the rat central nervous system.
    Sarret P; Perron A; Stroh T; Beaudet A
    J Comp Neurol; 2003 Jul; 461(4):520-38. PubMed ID: 12746866
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Deletion mutation in the putative third intracellular loop of the rat neurotensin receptor abolishes polyphosphoinositide hydrolysis but not cyclic AMP formation in CHO-K1 cells.
    Yamada M; Yamada M; Watson MA; Richelson E
    Mol Pharmacol; 1994 Sep; 46(3):470-6. PubMed ID: 7935327
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A highly sensitive quantitative cytosensor technique for the identification of receptor ligands in tissue extracts.
    Lenkei Z; Beaudet A; Chartrel N; De Mota N; Irinopoulou T; Braun B; Vaudry H; Llorens-Cortes C
    J Histochem Cytochem; 2000 Nov; 48(11):1553-64. PubMed ID: 11036098
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sustained neurotensin exposure promotes cell surface recruitment of NTS2 receptors.
    Perron A; Sharif N; Gendron L; Lavallée M; Stroh T; Mazella J; Beaudet A
    Biochem Biophys Res Commun; 2006 May; 343(3):799-808. PubMed ID: 16564027
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Complex actions of neurotensin in ascending and sigmoid colonic muscle: Involvement of enteric mediators.
    Azriel Y; Liu L; Burcher E
    Eur J Pharmacol; 2010 Oct; 644(1-3):195-202. PubMed ID: 20615399
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.